Skip to content

Regulatory Services

Unwavering access to country specific in-house regulatory experts, to facilitate product development and study success

Knowledge and Expertise You Can Rely On

SanaClis remains your trusted partner for all international and local regulatory requirements applicable to your project. Our regulatory department is comprised and lead by renowned regulatory figures, whom having previously held senior board level positions within international regulatory bodies, such as the EMA, FDA.  The dedicated regulatory team work in close cooperation with each sponsor to achieve full adherence to local and regional regulatory requirements, including expert counsel on all Supply Chain regulatory considerations, such as local labelling requirements etc.

Our Regulatory Services Include

  • Initial submission strategy
  • Submission of substantial, non-substantial amendments and notifications,
  • Definition of the submission requirements for each RA/EC including timing and any applicable fees
  • Specification of project deliverables including timing, roles & responsibilities, and resources
  • Definition which standards and/or regulations may be applicable for each potential country
  • Preparation of the whole submission package/dossier & QC
  • Submission the dossier via CTIS
  • Preparation only specific documents per country
  • Preparation of harmonized submission dossier via CTIS (Clinical Trial Information System) in EU countries
  • Flexibility in CTIS different roles based upon sponsor needs
  • Management of Request of Information (RFI) received via CTIS
  • Labelling preparation including master label text, country-specific label text, translations and review
  • Global support with local regulatory and labelling intelligence - early engagement with sponsors internal departments to ensure appropriate planning inclusions within IMPD submissions
  • Advisory and full adherence to local regulatory/labelling requirements, for centrally and locally sourced products. 

Streamlined Regulatory Pathways 

Regulatory and regulatory-scientific affairs in the clinical trials sphere is rapidly changing, mainly in the context of several regulations and many recent guidelines that have been implemented by various regulatory bodies.

The SanaClis Regulatory department provides management of Clinical Trial Application submissions to Regulatory Authorities, Ethic Committees and other relevant official bodies that could be involved in the process approval of investigational medicinal product and medical devices. This covers the initial clinical trial applications (CTA) and any other life-cycle submissions required to maintain the CTA such as amendments, notifications, clinical study report. Regular contact and communication with the RA/EC throughout the Clinical Trial is a standard norm.

1sanaclis color@0.5x-100

Clinical Trial Information System (CTIS)

CTIS is the online system for the regulatory submission, authorization and supervision of clinical trials in the EU and the European Economic Area. It is a single-entry point for all clinical trial data. As of 31st January 2023, the use of the CTIS  is mandatory for all initial submissions.

SanaClis is fully prepared to support our clients during this transition, allowing them to significantly reduce time and cost, while standardizing their processes within EU Member States and the EEA.

Find out more

Speak to an Expert

Reach out to our team of experts to discuss your project needs.

Contact Us


Latest articles